CORE LABORATORIES INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$138M
↑+7.0% +$9Mvs FY2024 (Q4)
Gross Profit
$29M
↑+24.7% +$6Mvs FY2024 (Q4)
Operating Income
$16M
↑+11.7% +$2Mvs FY2024 (Q4)
Net Income
$5M
↓-33.2% -$2Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $138M | $129M |
| COGS | $110M | $106M |
| Gross Profit | $29M | $23M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $4M | $4M |
| Other OpEx | $9M | $5M |
| Operating Income | $16M | $14M |
| Interest Exp. | $3M | $3M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $13M | $12M |
| Tax | $8M | $4M |
| Net Income | $5M | $7M |
QuarterCharts · SEC EDGAR data · CLB · Comparing FY2025 (Q4) vs FY2024 (Q4)